MIT researchers use physics technology to develop rapid COVID-19 test
Skip to main content
MDHC_Logotype_white
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • This Week's News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • People
    • Regional News
    • Digital Edition
    • Encompass Health reports minor gains in fourth quarter, predicts 8% growth in 2021
      Lab stakeholders welcome Biden moves on COVID-19 testing, suggest additional steps
      Humana names first chief equity officer
      Amid COVID health worker shortage, foreign-trained professionals sit on sidelines
    • Lab stakeholders welcome Biden moves on COVID-19 testing, suggest additional steps
      Amid COVID health worker shortage, foreign-trained professionals sit on sidelines
      J&J 4Q sales rise despite pandemic, but charges cut profits
      Biden administration to boost vaccine supply amid shortages
    • Ascension’s St. Mary’s Hospital Surgery Center at Towne Centre and Allegheny Health Network’s Bethel Park surgery center
      Hospitals see opportunity, risk in ambulatory surgery centers
      Health suffers as rural hospitals close
      Medicare ACO participants fell in 2021
      Louisiana gets reports vaccine providers are discriminating
    • Billing, antitrust exemption changes upend negotiations between insurers and providers
      MAIN-Health Bill_iStock_i.jpg
      Insurance-tech firm MultiPlan makes $155M buy after blank-check deal
      Last-minute COVID costs cut into UnitedHealthcare's $396 million operating income
      CMS approves rule forcing insurers to ease prior authorization
    • CMS pauses three Trump-era proposed rules
      Biden administration to boost vaccine supply amid shortages
      It's a secret: California keeps key virus data from public
      lacewell_linda_supertinendent_dept_of_financial_services_8.47.jpg
      New York state investigates drug price spikes during pandemic
    • KPMG says deal activity will stay high in '21: 10 takeaways
      By the Numbers: 20 largest healthcare investment banks in 2020
      Providers await new HHS coronavirus grant reporting deadline
      Operation Warp Speed Dr. Moncef Slaoui, Pfizer Group President Angela Hwang, Moderna CEO Stephane Bancel, CVS Health Executive Vice President Karen Lynch and McKesson CEO Brian Tyler participate in a panel discussion on the COVID-19 vaccine.
      Hospitals, drug companies strive to stand out virtually at JPM
    • Studies extend hopes for antibody drugs against COVID-19
      Google to convert office space for COVID-19 vax clinics
      Dr. Karen DeSalvo
      Next Up Podcast: What to expect with telehealth and healthcare technology in the next four years
      Next Up Podcast: What to expect with telehealth and healthcare technology in the next 4 years - Transcript
    • Amid COVID health worker shortage, foreign-trained professionals sit on sidelines
      China pushes conspiracy theories on COVID origin, vaccines
      Avocado
      Avocado a day keeps the doctor away
      50% of Americans make resolutions. Fewer than 27% keep them over time.
      Data Points: Sticking with your resolutions
    • Humana names first chief equity officer
      WEb_i.jpg
      Q&A: Dr. Cliff Megerian, University Hospitals' soon-to-be CEO
      ZentyWeb_i.jpg
      Tom Zenty is leaving a legacy of transformational growth at University Hospitals
      Cerner names Erceg as new CFO
    • Midwest
    • Northeast
    • South
    • West
  • Insights
    • ACA 10 Years After
    • Best Practices
    • InDepth Special Reports
    • Innovations
    • The Affordable Care Act after 10 years
    • New care model helps primary-care practices treat obesity
      doctor with patient
      COVID-19 treatment protocol developed in the field helps patients recover
      Rachel Wyatt
      Project to curb pressure injuries in hospitals shows promise
      Yale New Haven's COVID-19 nurse-staffing model has long-term benefits
    • Dr. James Hildreth
      How medical education can help fight racism
      Modern Healthcare InDepth: Breaking the bias that impedes better healthcare
      Videos: Healthcare industry executives describe their encounters with racism
      Michellene Davis
      Healthcare leadership lacks the racial diversity needed to reduce health disparities
      Hospital divided into multiple pieces
      Health systems may be warming to offshoring, a mainstay practice for insurers
    • A phone screen showing the question, "Mary we hope this information was helpful and we'd like to keep guiding you. Are you interested in knowing when it's your turn to receive the vaccine?"
      Chatbots, texting campaigns help manage influx of COVID vax questions
      A woman with a wearable sensor talking to her provider.
      Wearable sensors help diagnose heart rhythm problems in West Virginia
      self service station
      COVID-19 pushes patient expectations toward self-service
      Targeting high-risk cancer patients with genetics
  • Transformation
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Highmark Health inks six-year cloud, tech deal with Google
      Study: 1 in 5 patients report discrimination when getting healthcare
      HHS proposes changing HIPAA privacy rules
      Android health records app launches at 230 health systems
    • California hospitals prepare ethical protocol to prioritize lifesaving care
      Amazon, JPMorgan Chase, Berkshire Hathaway disband Haven
      Digital pathways poised to reshape healthcare continuum in 2021
      Healthcare was the hardest hit by supply shortages across all U.S. industries
    • A phone screen showing the question, "Mary we hope this information was helpful and we'd like to keep guiding you. Are you interested in knowing when it's your turn to receive the vaccine?"
      Chatbots, texting campaigns help manage influx of COVID vax questions
      A woman with a wearable sensor talking to her provider.
      Wearable sensors help diagnose heart rhythm problems in West Virginia
      New care model helps primary-care practices treat obesity
      How hospitals are building on COVID-19 telehealth momentum
    • Regional insurers bet big on virtual-first plans
      MedPAC votes to boost hospital payments, freeze or cut other providers
      Most Next Gen ACOs achieved bonuses in 2019
      Congress recalibrates Medicare Physician Fee Schedule after lobbying
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
    • Health Systems Financials
      Executive Compensation
      Physician Compensation
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
    • Wellstar CEO calls adapting for the pandemic her bold move
      Howard P. Kern
      Recognizing the value of telehealth in its infancy
      Dr. Stephen Markovich
      A bold move helped take him from family doctor to OhioHealth CEO
      Dr. Bruce Siegel
      Why taking a hospital not-for-profit was Dr. Bruce Siegel’s boldest move
    • Barry Ostrowsky
      Ending racism is a journey taken together; the starting point must be now
      Laura Lee Hall and Gary Puckrein
      Increased flu vaccination has never been more important for communities of color
      John Daniels Jr.
      Health equity: Making the journey from buzzword to reality
      Mark C. Clement and David Cook
      We all need to 'do something' to fight inequities and get healthcare right, for every patient, every time
    • The missing piece in our fight against COVID-19: primary care
      Ambulatory surgery centers offer extraordinary value in a high-cost healthcare system
       Alan B. Miller
      Looking ahead with optimism as we continue to transform healthcare
      Dr. Bruce Siegel
      By protecting the healthcare safety net, Biden can put us on the path to a stronger country
    • Letters: Eliminating bias in healthcare needs to be ‘deliberate and organic’
      Letters: Maybe dropping out of ACOs is a good thing for patients
      Letters: White House and Congress share blame for lack of national COVID strategy
      Letters: VA making strides to improve state veterans home inspections
    • Sponsored Content Provided By Optum
      How blockchain could ease frustration with the payment process
      Sponsored Content Provided By Optum
      Three steps to better data-sharing for payer and provider CIOs
      Sponsored Content Provided By Optum
      Reduce total cost of care: 6 reasons why providers and payers should tackle the challenge together
      Sponsored Content Provided By Optum
      Why CIOs went from back-office operators to mission-critical innovators
  • Awards
    • Award Programs
    • Nominate
    • Previous Award Programs
    • Other Award Programs
    • Best Places to Work in Healthcare Logo for Navigation
      Nominations Open - Best Places to Work in Healthcare
      Nominations Open - Health Care Hall of Fame
      Nominations Open - 50 Most Influential Clinical Executives
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Top 25 Minority Leaders
    • Top 25 Women Leaders
    • Excellence in Nursing Awards
    • Design Awards
    • Top 25 COOs in Healthcare
    • 100 Top Hospitals
    • ACHE Awards
  • Events
    • Conferences
    • Galas
    • Webinars
    • COVID-19 Event Tracker
    • Sponsored Content Provided By NTT DATA
      Webinar: Mistakes I’ve Made — Confessions of a Healthcare Cybersecurity Expert
      bright.md logo lockup webinar
      Sponsored Content Provided By Bright.md
      Webinar: Enabling a hybrid care model — Streamlining the patient path to both telehealth and in-person care
    • Leadership Symposium
    • Healthcare Transformation Summit
    • Women Leaders in Healthcare Conference
    • Workplace of the Future Conference
    • Strategic Marketing Conference
    • Social Determinants of Health Symposium
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Minority Leaders Gala (2022)
    • Top 25 Women Leaders Gala
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
    • Dr. Karen DeSalvo
      Next Up Podcast: What to expect with telehealth and healthcare technology in the next four years
      Carter Dredge
      Next Up Podcast: Ready, set, innovate! Innovation and disruption in healthcare
      Next Up Podcast: COVID-19, social determinants highlight health inequities — what next?
      Ceci Connolly
      Next Up Podcast: How to navigate the murky post-election waters
    • Beyond the Byline: Regulators aim to boost value push with fraud and abuse law updates
      An older man wearing a mask receiving a vaccine.
      Beyond the Byline: Verifying information on the chaotic COVID-19 vaccine rollout
      doctor burnout
      Beyond the Byline: How healthcare supply chain struggles contribute to employee burnout
      Beyond the Byline: Covering race and diversity in the healthcare industry
    • Leading intention promote diversity and inclusion
      Introducing Healthcare Insider Podcast
    • The Check Up: Dr. Joseph Kerschner
      The Check Up: Dr. Joseph Kerschner of the Medical College of Wisconsin
      The Check Up: Chip Kahn
      The Check Up: Chip Kahn of the Federation of American Hospitals
      The Check Up: Trenda Ray
      The Check Up: Trenda Ray of the University of Arkansas for Medical Sciences
      The Check Up: Dr. Kenneth Davis
      The Check Up: Dr. Kenneth Davis of Mount Sinai Health System
    • Video: Ivana Naeymi Rad of Intelligent Medical Objects
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Supply Chain
November 06, 2020 10:58 AM

MIT researchers use physics technology to develop rapid COVID-19 test

Kelsy Ketchum
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print

    While PCR-, antigen-, and antibody-based technologies have been the backbone technologies in the development of COVID diagnostics tests, other methods not usually used in the life sciences are also being explored as strategies to improve the detection of the coronavirus.

    In that vein, a team at Massachusetts Institute of Technology led by Alfredo Alexander-Katz, an associate professor of materials science and engineering at the school and cofounder of TriboSense Technologies, has adapted technology, typically used for physics applications, to create a rapid antigen COVID test that has been able to detect viral proteins in minutes with high accuracy.

    Trained as a theoretical physicist, Alexander-Katz thought that the problems and bottlenecks that confronted COVID-19 testing early on in the pandemic would be solved by now, hence his late entry into the field – his team has only been working on the application of the TriboSense instrument for diagnostic use since early summer.

    But with the number of coronavirus cases in the U.S. and Europe once again soaring to record numbers, the need for more testing has again moved to the forefront, with some pushing for more rapid antigen-based testing. Such tests, though, have been hampered by less than ideal accuracy. TriboSense's technology, Alexander-Katz thought, could offer a solution.

    The value proposition of TriboSense's test, according to Alexander-Katz, is that it delivers high accuracy with fast time to results and at the point of care. The test, called TriboSense One, doesn't have an optical readout for detecting viruses like many current tests on the market, but instead provides a mechanical readout to assess the strength of biomolecular interactions, looking at friction to detect a sample's molecular interactions and confirm the presence of the virus in very small concentrations, Alexander-Katz said.

    The instrument measures how molecules in saliva affect the motion of sensing beads with magnetic properties to determine whether SARS-CoV-2 viruses are present or not. The beads and the saliva are mixed together during sample prep. Currently, the firm's test detects the spike protein of the virus, but given the versatility of the test, the magnetic sensing particles can be customized to stick to different types of proteins, or example the nucleocapsid protein of SARS-CoV-2, which the firm is also pursuing.

    The technology is based on increasing the binding strength of the sensing beads to a substrate via the molecules or viruses one is looking for. Alexander-Katz used an analogy of trying to rotate a big wheel on "a perfectly icy surface" to describe the technology. Normally it would slip. But now, "let's imagine, [you have] this little ball that has spikes on it, and these spikes could either penetrate or stick to the surface of the big wheel and the ice, so that would give you traction. The moment you get traction, you will start moving," he said. "You get more friction and you're able to translate a larger distance – that's what we're actually measuring." In this analogy, the virus is the ball with spikes and researchers are using microscopic magnetic spheres as the big wheels that are being rotated. By detecting how they move they're able to know if there's virus present in the sample.

    According to the company, TriboSense One has a sample run time of less than a minute and prep time of five minutes or less, meaning up to 500 tests can be run per hour. That, said Heather Signorelli, VP and chief laboratory officer at HCA Healthcare, is one of the test's selling points and one reason her organization is looking into learning more about the instrument and test.

    "The biggest issue [for COVID-19 testing] is that you need a varying degree of vendors in order to satisfy the capacity needs," she said. "At HCA we're using over 20 different cartridge types across the company. We have antigen, we have isothermal nucleic amplification, we have PCR, really a lot of different things." The TriboSense test could provide another highly sensitive option for testing at the point of care in these settings.

    The test uses saliva samples. Once the sample is collected, the consumer only has to do "very simple work" on it, mostly pipetting the sample into the solution, Alexander-Katz said.

    The team is developing its COVID test to run directly on the instrument, which costs about $2,000 per instrument to build, although Joe Donahue, the company's chairman of the board and a former managing director at Accenture Life Sciences, said that once the firm is able to scale up, that cost could drop to about $1,000. He added that the company isn't planning to make money on the instrument and instead will provide it free to organizations that sign up to use the test. The test itself would be between $5 and $6, he added.

    Currently, the firm has hard data on spike samples using a model system, and Alexander-Katz said the limit of detection is between five and 10 viral copies per microliter, comparable to PCR tests on the market. He also said the team is considering submitting their eventual data as a manuscript for publication. The models have been performed repeatedly with high accuracy, but more field validation is needed to confirm its accuracy.

    TriboSense hasn't compared its test side by side with other rapid antigen tests, Alexander-Katz said, because it doesn't have access to those samples.

    While sensitivity is crucial for COVID-19 tests, especially at the point of care, Signorelli said there needs to be a bigger push for at-home testing, even if their sensitivity doesn't match the performance of PCR tests, the gold standard for SARS-CoV-2 testing. "Right now, we have antigen tests and they're okay, they aren't as sensitive, and we are seeing some both false positives … as well as false negatives."

    Earlier this week, the Food and Drug Administration released a letter warning labs and healthcare providers about potential false positives when using rapid antigen tests.

    TriboSense is talking with two unnamed large hospital systems, as well, to start surveillance testing for the eventual submission of the test and instrument to the FDA for emergency use authorization, Donahue added. The hospital systems are interested in using TriboSense's test in parallel with their current PCR tests, he said.

    "We've actually already started some of the conversations with everything from schools, some businesses, an airline," Donahue said. The firm is looking for $500,000 to $1 million in funding to "ramp up, build more instruments, get the test ready," and once that funding goal is met the company will be ready to conduct studies in about three weeks, he continued. Depending on FDA EUA, the company said it would be ready to deploy platform testing within three months of receiving funding.

    So far, the development has been all self-funded primarily by Alexander-Katz with no external funding in the few months the company has been around. The TriboSense Mechanically-Transduced Immunosorbent Assay technology, which unlike the TriboSense testing system, was patented in 2013 by Alexander-Katz and his partner and cofounder at TriboSense Joshua Steimel. According to Alexander-Katz, the idea to look at the technology for ways to adapt it as a diagnostics tool came at the end of May or beginning of June.

    "I think everybody's desperate to go back to normal," he said, but with the current state of testing, "I don't think we're going to get there as it's going right now."

    The technology was originally created to measure protein-protein, protein-DNA, DNA-DNA and other biomolecular interactions to detect and quantify how strong the interactions are. "We had to go from scratch," he continued. "We had never worked on viruses … and we adapted the technology to be able to do this."

    Donahue said that the instrument would work particularly well for multiplex tests detecting SARS-CoV-2 and influenza because there's a lot of flexibility to test for different antigens in the SARS-CoV-2 virus and other viruses. Alexander-Katz said they eventually want to expand testing to other diseases, but the imminent focus is on COVID-19. "We think that this is an excellent avenue for immunoassays," he said.

    Combination testing for influenza and SARS-CoV-2 that detects from one swab is another major need, Signorelli said, because patients don't want to have multiple "brain swabs" taken and a lot of POC equipment on the market today requires multiple swabs. In particular, she noted the strong desire for CLIA-waived tests that can be run by nursing staff and other healthcare providers.

    Donahue said that the instrument would have the biggest impact in point-of-care settings due to its small footprint and portability – it's "a little bit smaller than a desktop computer," he said. "It's really small and just highly portable, and the reagents are really simple."

    The team hasn't done work to adapt the platform and test for home use yet but said it would potentially be suitable for use in airports, restaurants, office buildings, and hospitals to provide rapid, accurate results. TriboSense is also having conversations with diagnostic and laboratory testing companies who could help scale up manufacturing of the test and instrument, although he declined to identify them.

    In terms of reimbursement, although the test costs about $5 to $6 right now, at scale it could cost as little as $3, making it potentially attractive to payors, according to Donahue.

    This story first appeared in our sister publication, 360Dx, which provides in-depth coverage of in vitro diagnostics and the clinical lab market.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Lab stakeholders welcome Biden moves on COVID-19 testing, suggest additional steps
    Lab stakeholders welcome Biden moves on COVID-19 testing, suggest additional steps
    J&J 4Q sales rise despite pandemic, but charges cut profits
    J&J 4Q sales rise despite pandemic, but charges cut profits
    Sponsored Content
    Get Free Newsletters

    Sign up for free enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today

    The weekly magazine, websites, research and databases provide a powerful and all-encompassing industry presence. We help you make informed business decisions and lead your organizations to success.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS
    • Instagram

    Stay Connected

    Join the conversation with Modern Healthcare through our social media pages

    MDHC_Logotype_white
    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2021. Crain Communications, Inc. All Rights Reserved.
    • News
      • This Week's News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition
    • Insights
      • ACA 10 Years After
      • Best Practices
      • InDepth Special Reports
      • Innovations
    • Transformation
      • Patients
      • Operations
      • Care Delivery
      • Payment
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Award Programs
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Top 25 Minority Leaders
        • Top 25 Women Leaders
      • Nominate
      • Previous Award Programs
        • Excellence in Nursing Awards
        • Design Awards
        • Top 25 COOs in Healthcare
      • Other Award Programs
        • 100 Top Hospitals
        • ACHE Awards
    • Events
      • Conferences
        • Leadership Symposium
        • Healthcare Transformation Summit
        • Women Leaders in Healthcare Conference
        • Workplace of the Future Conference
        • Strategic Marketing Conference
        • Social Determinants of Health Symposium
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Minority Leaders Gala (2022)
        • Top 25 Women Leaders Gala
      • Webinars
      • COVID-19 Event Tracker
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing